Mae gwerthwchigymru.llyw.cymru yn defnyddio cwcis sy'n hanfodol er mwyn i'r safle weithio. Rydym hefyd yn defnyddio cwcis nad ydynt yn hanfodol i'n helpu i wella gwasanaethau digidol y Llywodraeth. Mae unrhyw ddata a gesglir yn ddienw. Drwy barhau i ddefnyddio'r safle hwn, rydych yn cytuno i'n defnydd o gwcis

Derbyn ein defnydd o gwcis Gosodiadau cwcis

Gweld Hysbysiad

Hoffech chi gofnodi diddordeb yn yr hysbysiad hwn?

Manylion yr Hysbysiad

Teitl: COVID-19 Antigen testing on Starlet and Nimbus platforms in Microbiology Laboratories across Wales
Cyhoeddwyd gan: NHS Wales Shared Services Partnership
Dyddiad Cyhoeddi: 29/05/20
Dyddiad Cau:
Amser Cau:
Math o Hysbysiad: SF15 Voluntary ex ante transparency notice
Yn Cynnwys Dogfennau: Na
Yn ESPD: Na
Crynodeb: COVID-19 Antigen testing on Starlet and Nimbus platforms in Microbiology Laboratories across Wales
CPV: 33696500, 33696500.

Voluntary ex ante transparency notice

Directive 2014/24/EU

Section I: Contracting Change entity

I.1) Name and addresses

NHS Wales Shared Services Partnership

4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw

Cardiff

CF15 7QZ

UK

Telephone: +44 1443848585

E-mail: shannon.mason@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://www.procurement.wales.nhs.uk

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

COVID-19 Antigen testing on Starlet and Nimbus platforms in Microbiology Laboratories across Wales

Reference number: PHW-STA-432

II.1.2) Main CPV code

33696500

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

COVID-19 Antigen testing on Starlet and Nimbus platforms in Microbiology Laboratories across Wales

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

33696500

II.2.3) Place of performance

NUTS code:

UKL

II.2.4) Description of the procurement

NHS Wales Shared Service Partnership on behalf of Public Health Wales NHS Trust wish to inform the market that due to the Covid-19 global pandemic they are awarding a contract for the provision of testing kits, equipment, reagents and any other associated consumables required to operate the testing platforms.

The UK government has mandated UK Health Boards and Trusts to carry out antibody and antigen testing for the wider population as well as those working in Healthcare and Care settings.

Therefore in order to enable the provision of these testing kits, equipment, reagent and other associated consumables required to operate the testing platforms, Public Health Wales would like to inform the market that under Regulation 32 (2) (C) of the Public Contracts Regulations 2015 (PCR’s) as detailed in UK Government guidance PPN 01/20 they are awarding a contract to MAST.

The Trust has met all the tests for awarding a contract under this regulation due to the immediate risk that COVID-19 poses to the population of Wales.

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

N/A

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the Official Journal of the European Union

Justification for selected award procedure:

The procurement falls outside the scope of application of the Directive

Explanation:

Coronavirus Disease (COVID-19) is an infection disease caused by a newly discovered Coronavirus.

The UK Government published the requirement for testing to be available for Healthcare professionals, key workers and the wider population of Wales, to monitor and work to prevent the rate of the spread of infection.

Following engagement with the market and the Public Health Wales Microbiology department, the testing kits, equipment, reagent and other associated consumables required to operate the testing platforms were deemed clinically acceptable and the products have been available for immediate purchase within the market.

The award of these products enables the Trust to increase their testing capacity, in line with the expectations and demands of the Welsh Government strategy in tackling the Coronavirus (COVID-19) pandemic.

In these exceptional circumstances, there is no time to run an accelerated procedure in line with PCR’s as there is an urgent requirement for suitable testing kits, equipment, reagents and other associated consumables required to support the use of the testing platforms.

Based on the above, the authority is applying a 10 day standstill period to allow suppliers in the marketplace an opportunity to appeal if they believe they have the capacity to meet the Trusts unique and urgent requirements.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section V: Award of contract/concession

Contract No: PHW-STA-432

V.2 Award of contract/concession

V.2.1) Date of conclusion of the contract/concession

27/05/2020

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

N.A

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=101966.

(WA Ref:101966)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

Telephone: +44 2079477501

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

NHS Wales Shared Services Partnership on behalf of Public Health Wales Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.

Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments).

VI.5) Date of dispatch of this notice

27/05/2020


Gwybodaeth a ychwanegwyd at yr hysbysiad ers iddo gael ei gyhoeddi.

Additional information added to the notice since it's publication.
Nid oes unrhyw wybodaeth bellach wedi'i lanlwytho.
Prif Gyswllt: shannon.mason@wales.nhs.uk
Cyswllt Gweinyddol: Dd/g
Cyswllt Technegol: Dd/g
Cyswllt Arall: Dd/g

Categorïau Nwyddau

Commodity Categories
Rhif AdnabodTeitlPrif Gategori
33696500Laboratory reagentsReagents and contrast media

Lleoliadau Dosbarthu

Delivery Locations
Rhif AdnabodDisgrifiad
1018Abertawe
1022Caerdydd a Bro Morgannwg
1013Conwy a Sir Ddinbych
1015Cymoedd Canalog (Merthyr Tudful, Rhondda Cynon Taf)
1016Cymoedd Gwent (Torfaen, Blaenau Gwent, Caerffili)
1000CYMRU
1014De-orllewin Cymru (Sir Gaerfyrddin, Sir Benfro, Ceredigion)
1020Dwyrain Cymru
1010Gorllewin Cymru a'r Cymoedd
1012Gwynedd
1017Pen-y-bont ar Ogwr a Castell-Nedd Port Talbot
1024Powys
1021Sir Fynwy a Chasnewydd
1023Sir y Fflint a Wrecsam
1011Ynys Môn

Cyfyngiadau Rhanbarthol ar y Rhybuddion

Mae’r prynwr wedi cyfyngu’r rhybuddion ar gyfer yr hysbysiad hwn i gyflenwyr yn y rhanbarthau canlynol.

Alert Region Restrictions
Nid oes cyfyngiadau ar y rhybuddion ar gyfer yr hysbysiad hwn.

Cyfarwyddiadau Pellach

Mae'r Prynwr wedi atodi cyfarwyddiadau pellach i'r hysbysiad hwn. Darllenwch y rhain yn ofalus a chymerwch y cam(au) gweithredu angenrheidiol.

Cofnodwch eich diddordeb yn yr hysbysiad hwn a chaiff unrhyw eglurhad, newidiadau i ddyddiadau cau ac ati eu hanfon atoch yn awtomatig. Nid yw'r ffaith eich bod wedi cofnodi eich diddordeb yn golygu y cewch eich cynnwys yn awtomatig yn y broses dendro ar cliciwch ar y botwm Cofnodwch eich diddordeb nawr ar frig y dudalen.

Copyright © GwerthwchiGymru